These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 23876679)

  • 41. Donor-Derived Exosomes With Lung Self-Antigens in Human Lung Allograft Rejection.
    Gunasekaran M; Xu Z; Nayak DK; Sharma M; Hachem R; Walia R; Bremner RM; Smith MA; Mohanakumar T
    Am J Transplant; 2017 Feb; 17(2):474-484. PubMed ID: 27278097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alloimmunity and autoimmunity in chronic rejection.
    Seetharam A; Tiriveedhi V; Mohanakumar T
    Curr Opin Organ Transplant; 2010 Aug; 15(4):531-6. PubMed ID: 20613527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies.
    Yousem SA; Zeevi A
    Am J Surg Pathol; 2012 Jul; 36(7):987-92. PubMed ID: 22510758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
    Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic effect of antibodies to human leukocyte antigens and defensins in pathogenesis of bronchiolitis obliterans syndrome after human lung transplantation.
    Saini D; Angaswamy N; Tiriveedhi V; Fukami N; Ramachandran S; Hachem R; Trulock E; Meyers B; Patterson A; Mohanakumar T
    J Heart Lung Transplant; 2010 Dec; 29(12):1330-6. PubMed ID: 20691611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical relevance of lung-restricted antibodies in lung transplantation.
    Akbarpour M; Wu Q; Liu X; Sun H; Lecuona E; Tomic R; Bhorade S; Mohanakumar T; Bharat A
    Hum Immunol; 2019 Aug; 80(8):595-601. PubMed ID: 31078336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological link between primary graft dysfunction and chronic lung allograft rejection.
    Bharat A; Kuo E; Steward N; Aloush A; Hachem R; Trulock EP; Patterson GA; Meyers BF; Mohanakumar T
    Ann Thorac Surg; 2008 Jul; 86(1):189-95; discussion 196-7. PubMed ID: 18573422
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An obligatory role for lung infiltrating B cells in the immunopathogenesis of obliterative airway disease induced by antibodies to MHC class I molecules.
    Fukami N; Ramachandran S; Takenaka M; Weber J; Subramanian V; Mohanakumar T
    Am J Transplant; 2012 Apr; 12(4):867-76. PubMed ID: 22233464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Humoral Response in Liver Allograft Transplantation: A Review of the Role of Anti-Human Leukocyte Antigen (HLA) Antibodies.
    Muro M; Moya-Quiles MR; Mrowiec A
    Curr Protein Pept Sci; 2016; 17(8):776-784. PubMed ID: 26916161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of miRNA-155 in the immunopathogenesis of obliterative airway disease in mice induced by circulating exosomes from human lung transplant recipients with chronic lung allograft dysfunction.
    Bansal S; Itabashi Y; Perincheri S; Poulson C; Bharat A; Smith MA; Bremner RM; Mohanakumar T
    Cell Immunol; 2020 Sep; 355():104172. PubMed ID: 32707293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specific Donor HLA-DR Types Correlate With Altered Susceptibility to Development of Chronic Lung Allograft Dysfunction.
    Haynes LD; Julliard WA; Mezrich JD; Leverson G; Meyer KC; Burlingham WJ
    Transplantation; 2018 Jul; 102(7):1132-1138. PubMed ID: 29360666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A decline in club cell secretory proteins in lung transplantation is associated with release of natural killer cells exosomes leading to chronic rejection.
    Ravichandran R; Itabashi Y; Liu W; Bansal S; Rahman M; Poulson C; Fleming T; Bremner RM; Smith M; Mohanakumar T
    J Heart Lung Transplant; 2021 Dec; 40(12):1517-1528. PubMed ID: 34627707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
    Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Indirect recognition and antibody production against a single mismatched HLA-A2-transgenic molecule precede the development of obliterative airway disease in murine heterotopic tracheal allografts.
    Smith MA; Jaramillo A; SivaSai KS; Naziruddin B; Kaleem Z; Patterson GA; Mohanakumar T
    Transplantation; 2002 Jan; 73(2):186-93. PubMed ID: 11821728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19 in a lung transplant recipient: Exploring the diagnostic role of circulating exosomes and the clinical impact of advanced immunosuppression.
    Goodlet KJ; Bansal S; Arjuna A; Nailor MD; Buddhdev B; Abdelrazek H; Mohamed H; Omar A; Walia R; Mohanakumar T; Tokman S
    Transpl Infect Dis; 2021 Apr; 23(2):e13480. PubMed ID: 32997881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
    Lobo LJ; Aris RM; Schmitz J; Neuringer IP
    J Heart Lung Transplant; 2013 Jan; 32(1):70-7. PubMed ID: 23260706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
    Frank R; Dean SA; Molina MR; Kamoun M; Lal P
    Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease.
    Tiriveedhi V; Takenaka M; Ramachandran S; Gelman AE; Subramanian V; Patterson GA; Mohanakumar T
    Am J Transplant; 2012 Oct; 12(10):2663-74. PubMed ID: 22822907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.